Credit Suisse analyst A.J. Rice raised the firm’s price target on UnitedHealth to $610 from $590 as he makes no changes to his EPS estimates but rolls forward his valuation to 2024. The analyst keeps an Outperform rating on the shares.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on UNH:
- Citron goes short Agilon, says Supreme Court ‘torpedoed’ business
- Craig-Hallum upgrades eHealth to Buy on ‘clear signs of life’
- Managed care company returns will be tough to keep replicating, WSJ says
- UnitedHealth backs FY22 adjusted EPS view $21.85-$22.05, consensus $22.03
- UnitedHealth sees FY23 adjusted EPS $24.40-$24.90, consensus $24.94
